A detailed history of Empery Asset Management, LP transactions in Surrozen, Inc. stock. As of the latest transaction made, Empery Asset Management, LP holds 215,942 shares of SRZN stock, worth $2.64 Million. This represents 2.59% of its overall portfolio holdings.

Number of Shares
215,942
Previous 257,766 16.23%
Holding current value
$2.64 Million
Previous $773,000 43.6%
% of portfolio
2.59%
Previous 4.19%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.26 - $46.35 $10,874 - $1.94 Million
-41,824 Reduced 16.23%
215,942 $436,000
Q2 2022

Aug 12, 2022

SELL
$2.14 - $3.43 $163,065 - $261,362
-76,199 Reduced 22.82%
257,766 $773,000
Q1 2022

May 16, 2022

SELL
$2.2 - $6.01 $542,817 - $1.48 Million
-246,735 Reduced 42.49%
333,965 $1.01 Million
Q4 2021

Feb 11, 2022

BUY
$6.0 - $9.92 $3.48 Million - $5.76 Million
580,700 New
580,700 $3.74 Million

Others Institutions Holding SRZN

About Surrozen, Inc.


  • Ticker SRZN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,122,900
  • Market Cap $430M
  • Description
  • Surrozen, Inc., a biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair and regeneration. It is developing tissue-specific antibodies with application across various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, a...
More about SRZN
Track This Portfolio

Track Empery Asset Management, LP Portfolio

Follow Empery Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Empery Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Empery Asset Management, LP with notifications on news.